Uromems raised €52M in a Growth/Late round in May 2026. The company is based in Grenoble, France. Investors in the round: Ajax Health Fund I. Data as of 7 Aug 2026.
Confidence is the weaker of amount-FX and source evidence (the cascade rule). See methodology.
